Russell Investments Group, Ltd. Ligand Pharmaceuticals Inc Transaction History
Russell Investments Group, Ltd.
- $69.8 Billion
- Q4 2024
A detailed history of Russell Investments Group, Ltd. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 95,600 shares of LGND stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
95,600
Previous 116,254
17.77%
Holding current value
$10.3 Million
Previous $11.6 Million
12.04%
% of portfolio
0.01%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding LGND
# of Institutions
277Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$310 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$225 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$110 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$95.5 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$80.3 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.82B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...